MYC and ovarian cancer: Recently, Majem et al. also found that miR-654-5p is downregulated in ovarian serous carcinomas and restoration suppresses ovarian cancer development by impacting on the oncogenic function of MYC, AKT and Wnt pathways through directly targeting CDCP1 and PLAGL2 (97).